Search results for " brain injury"

showing 10 items of 135 documents

Xenon treatment improves short-term and long-term outcomes in a rodent model of traumatic brain injury

2018

Science & TechnologyTraumatic brain injurybusiness.industrySITE1103 Clinical SciencesRodent modelmedicine.diseaseCOMPETITIVE-INHIBITIONTerm (time)D-ASPARTATE RECEPTORAnesthesiology and Pain MedicineAnesthesiologyAnesthesiamedicineLong term outcomesbusinessLife Sciences & BiomedicineBritish Journal of Anaesthesia
researchProduct

Memory function after resolution of post traumatic amnesia

2005

Primary objectives: The aims of this pilot study were (1) to examine neuropsychological, particularly memory functions immediately after post-traumatic amnesia (PTA) resolution according to the Galveston Orientation and Amnesia Test (GOAT), and (2) to provide a preliminary exploration of pattern of performance on GOAT items across PTA duration. Methods and procedures: Thirty-seven head injured patients were administered the Recognition Memory Tests on the day that PTA resolved. Formal neuropsychological assessment was conducted on average 10 days after PTA resolution. Main outcomes and results: All the patients in the series showed memory impairment which varied in severity but was typicall…

Settore M-PSI/02 - Psicobiologia E Psicologia FisiologicaPost-traumatic amnesia memory traumatic brain injury
researchProduct

Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date

2014

Antonino Tuttolomondo, Rosaria Pecoraro, Antonio Pinto Biomedical Department of Internal and Specialistic Medicine, University of Palermo, Palermo, Italy Abstract: The brain is very actively involved in immune-inflammatory processes, and the response to several trigger factors such as trauma, hemorrhage, or ischemia causes the release of active inflammatory substances such as cytokines, which are the basis of second-level damage. During brain ischemia and after brain trauma, the intrinsic inflammatory mechanisms of the brain, as well as those of the blood, are mediated by leukocytes that communicate with each other through cytokines. A neuroinflammatory cascade has been reported to be activ…

Settore MED/09 - Medicina InternaTraumatic brain injurytumor necrosis factor inhibitorsCentral nervous systemIschemiaPharmaceutical ScienceReviewAMPA receptorEtanerceptBrain ischemiaTBIDrug DiscoverymedicineAnimalsHumansStroke trauma TNF-alfa antagonistPharmacologyMicrogliaTumor Necrosis Factor-alphabusiness.industrytraumatic brain injurylcsh:RM1-950Anti-Inflammatory Agents Non-Steroidalbrain injurymedicine.diseaseStrokelcsh:Therapeutics. Pharmacologymedicine.anatomical_structureBrain InjuriesImmunologyTumor necrosis factor alphabusinessmedicine.drugDrug Design, Development and Therapy
researchProduct

Neuroprotective properties of xenon and helium in an in vitro model of traumatic brain injury: one small step or one big jump?

2008

Settore MED/27 - Neurochirurgiabusiness.industryTraumatic brain injurychemistry.chemical_elementCritical Care and Intensive Care Medicinemedicine.diseaseNeuroprotectionXenum helium neuroprotectionIn vitro modelXenonchemistryAnesthesiaJumpMedicinebusinessAnesthetics; Inhalation; administration /&/ dosage/therapeutic use Animals Brain Injuries; prevention /&/ control Disease Models; Animal Helium; administration /&/ dosage/therapeutic use Mice Mice; Inbred C57BL Tissue Culture Techniques Xenon; administration /&/ dosage/therapeutic use
researchProduct

Treatments for intracranial hypertension in acute brain-injured patients: grading, timing, and association with outcome. Data from the SYNAPSE-ICU st…

2023

Purpose: Uncertainties remain about the safety and efficacy of therapies for managing intracranial hypertension in acute brain injured (ABI) patients. This study aims to describe the therapeutical approaches used in ABI, with/without intracranial pressure (ICP) monitoring, among different pathologies and across different countries, and their association with six months mortality and neurological outcome. Methods: A preplanned subanalysis of the SYNAPSE-ICU study, a multicentre, prospective, international, observational cohort study, describing the ICP treatment, graded according to Therapy Intensity Level (TIL) scale, in patients with ABI during the first week of intensive care unit (ICU) a…

Subarachnoid haemorrhageTraumatic brain injuryIntracranial pressureTherapy intensity levelCritical Care and Intensive Care MedicineIntracranial haemorrhageIntensive Care Medicine
researchProduct

The role of mitochondrial transition pore, and its modulation, in traumatic brain injury and delayed neurodegeneration after TBI

2009

Following severe traumatic brain injury (TBI), a complex interplay of pathomechanism, such as exitotoxicity, oxidative stress, inflammatory events, and mitochondrial dysfunction occurs. This leads to a cascade of neuronal and axonal pathologies, which ultimately lead to axonal failure, neuronal energy metabolic failure, and neuronal death, which in turn determine patient outcome. For mild and moderate TBI, the pathomechanism is similar but much less frequent and ischemic cell death is unusual, except with mass lesions. Involvement of mitochondria in acute post-traumatic neurodegeneration has been extensively studied during the last decade, and there are a number of investigations implicatin…

Time FactorsTraumatic brain injurymedicine.medical_treatmentMitochondrionMitochondrial Membrane Transport ProteinsNeuroprotectionBrain Ischemiachemistry.chemical_compoundDevelopmental NeuroscienceCyclosporin aAnimalsHumansMedicineMitochondrial Permeability Transition Porebusiness.industryMPTPNeurodegenerationmedicine.diseasenervous system diseasesnervous systemNeurologyMitochondrial permeability transition porechemistryBrain InjuriesReperfusion InjuryAcute DiseaseChronic DiseaseNerve DegenerationAxotomybusinessNeuroscience
researchProduct

Pharmacologic Inhibition of ADAM10 Attenuates Brain Tissue Loss, Axonal Injury and Pro-inflammatory Gene Expression Following Traumatic Brain Injury …

2021

The α-secretase A disintegrin and metalloprotease 10 (ADAM10) regulates various physiological and pathophysiological processes. Despite its broad functional implications during development, plasticity, and disease, no pharmacological approaches to inhibit ADAM10 in acute brain injury have been reported. Here, we examined the effects of the ADAM10 inhibitor GI254023X on the neurological and histopathological outcome after experimental traumatic brain injury (TBI). C57BL/6N mice were subjected to the controlled cortical impact (CCI) model of TBI or sham procedure and received GI254023X or vehicle during the acute phase of injury (n = 40, 100 mg/kg, 25% DMSO, 0.1 M Na2CO3, intraperitoneal, 30 …

Traumatic brain injuryADAM10PharmacologyBlood–brain barrierNeuroprotectionneuroinflammationaxonal injuryCell and Developmental Biologymedicinelcsh:QH301-705.5NeuroinflammationOriginal ResearchMicrogliabiologybusiness.industrytraumatic brain injuryADAM10 (a disintegrin and metalloprotease 10)Glutamate receptorCell Biologymedicine.diseaseGI254023Xmedicine.anatomical_structurelcsh:Biology (General)biology.proteinneuroprotectionGRIN2BbusinessDevelopmental BiologyFrontiers in Cell and Developmental Biology
researchProduct

Cisternostomy for Traumatic Brain Injury: A New Era Begins

2016

Traumatic brain injury (TBI) is a major cause of death and disability especially in the young generations. In the United States TBI affects about 1.7 million people annually [1] and this number is higher in the developing countries. It is well known that TBI is associated to a primary and secondary brain injury. The first is without solution and depends on the impact. In surviving patients, what plays a critical role is the subsequent secondary injury since, without effective treatments, complex cascades will promote additional brain damage.

Traumatic brain injuryEditorialCisternostomy; Microsurgical anatomy; Traumatic brain injurylcsh:Medical emergencies. Critical care. Intensive care. First aidlcsh:RC86-88.9Microsurgical anatomyCisternostomy
researchProduct

Does granulocyte-colony stimulating factor stimulate peripheral nerve regeneration? An experimental study on traumatic lesion of the sciatic nerve in…

2021

Aim of the study. To analyse the therapeutic potential of granulocyte-colony stimulating factor (G-CSF) treatment using a rat model of traumatic sciatic nerve lesion. Clinical rationale for the study. G-CSF has proven strong neurotrophic properties in various models of ischaemic and traumatic brain injury. Fewer studies exist regarding the influence of G-CSF on posttraumatic peripheral nerve regeneration. Currently, the possibilities of pharmacological prevention or treatment of mechanical nerve injury are limited, and there is an urgent need to find new treatment strategies applicable in clinical situations. Material and methods . A controlled traumatic right sciatic nerve lesion was set u…

Traumatic brain injuryLesionGranulocyte Colony-Stimulating FactormedicineAnimalsHumansbiologybusiness.industrySciatic nerve injuryNerve injurymedicine.diseaseSpinal cordSciatic NerveGranulocyte colony-stimulating factorNerve RegenerationRatsDisease Models Animalmedicine.anatomical_structureAnesthesiabiology.proteinSurgeryNeurology (clinical)Sciatic nervemedicine.symptomSciatic NeuropathybusinessNeurotrophinGranulocytesNeurologia i neurochirurgia polska
researchProduct

Hyperventilation in Adult TBI Patients: How to Approach It?

2021

Hyperventilation is a commonly used therapy to treat intracranial hypertension (ICTH) in traumatic brain injury patients (TBI). Hyperventilation promotes hypocapnia, which causes vasoconstriction in the cerebral arterioles and thus reduces cerebral blood flow and, to a lesser extent, cerebral blood volume effectively, decreasing temporarily intracranial pressure. However, hyperventilation can have serious systemic and cerebral deleterious effects, such as ventilator-induced lung injury or cerebral ischemia. The routine use of this therapy is therefore not recommended. Conversely, in specific conditions, such as refractory ICHT and imminent brain herniation, it can be an effective life-savin…

Traumatic brain injurybusiness.industrytraumatic brain injuryIschemiahyperventilationReviewLung injurymedicine.diseaseBrain herniationcerebral ischemialcsh:RC346-429hypocapniaHypocapniaCerebral blood flowNeurologyAnesthesiaintracranial hypertensionHyperventilationmedicineNeurology (clinical)medicine.symptombusinesslcsh:Neurology. Diseases of the nervous systemIntracranial pressureFrontiers in neurology
researchProduct